Quick To Clinic™ Small Molecule Oral Solid Dose

Drug developers advancing a therapy product toward commercialization face complex scientific challenges such as formulation, solubility, and bioavailability, each one introducing risk of delays or compromised product quality. Poorly characterized active pharmaceutical ingredients (APIs) can lead to costly development delays and waste, and complex supply chains can lead to frustrating communication and handoffs between partners.

Thermo Fisher Scientific’s Quick to Clinic™ Small Molecule OSD provides a solution to your scientific, resource, and supply chain challenges so you can make smarter decisions that minimize experimental effort and reduce risk. Explore how Quick to Clinic™ Small Molecule OSD enables a variety of in-silico modeling options that can provide the insights you need to avoid waste and delays later by using optimized characterization and solid-state chemistry. By integrating broad capabilities within one network, Quick to Clinic™ Small Molecule OSD can also help reduce complexity and risk in your value chain.